In Phase II Clinical Trials
Development of Effective and Innovative Medicines to Address the needs of Patients and Improve their Health, Longevity and Quality of Life.
Hub Controls
  • Control Panel Demo
  • Upload Photo
  • Edit Company Profile
  • Add a Link
  • Update Fast Facts
  • Add Management Bios
  • Private Messages
  • Edit Your Profile

Email Updates

AGORACOM News Flash

HAPPY 4TH OF JULY TO ALL OF OUR AMERICAN FRIENDS !!

 

AlphaRx > Message
Generic_profile

Re: Cypess Biosience

Posted by: Never_Post on April 14, 2008 02:18PM

In response to: Cypess Biosience by mavenwood

Mavenwood,

From my notes taken while listening to the Cypress Bioscience past conference call I wrote the following,

"More Phase II work was needed to satisfy Cypress Bioscience".

I vaguely recall something about more data being required by Cypress than had been made available to them.

I have no idea whether this meant the data had been captured and not made available or whether additional testing was needed to generate the data.

However, got the impression that Cypress would not be satisfied without the data and that I am inferring that more time would be needed before moving forward with Phase III.

If you find out specifics please let me know.

Best Regards

Post a Reply

Please login to reply to this message.

Executive Address
Alrxsmall
Michael Lee
President
May 18, 2006

 

Michael Lee provides the investor community an update on recent events

View Broadcast

Stock Quote